Articles by Ed Cara
Cancer treatment is often a difficult process, thanks in no small part to the many side effects it can cause. A study out this week, however, shows the perils of relying on less conventional remedies�...
Sometimes a little goes a long way. That just might be true when it comes to taking GLP-1 treatments like semaglutide (Ozempic and Wegovy) for weight loss, recent research finds.
Doctors at Scripps �...
The Winter Olympics in Italy this year could have an oddly shaped bump in the road. The world of elite ski jumping is currently beset by rumors of athletes artificially enlarging their penises to gai�...
Measles is making an unwelcome comeback in the United States, and the Centers for Disease Control and Prevention is looking to dodge any responsibility for it.
In a recent editorial for the Wall Str�...
Lots of Americans have a blood pressure problem, but plenty aren’t doing much to remedy it, according to research published today.
Scientists studied nationally representative data from Americans o...
The future of treating cancer might just include a dose of donated poop. A pair of small trials out this week have found that fecal microbiota transplantation (FMT)thankfully delivered via a pillcan �...
The growing popularity of GLP-1 drugs like Ozempic and Zepbound is having some unfortunate consequences. Namely, that some people, including children, are overdosing on the medications.
This week, I�...
Having colorblindness could be even more of a disadvantage than commonly thought. Research published this month might indicate that colorblind people are less able to literally spot certain cancers b�...
The enemy of our enemy could very well become our friend. Scientists have possibly uncovered a new approach to treating Alzheimer’s diseaseone tied to the development of cancer.
Researchers at the ...
A rare but potentially deadly fungal infection known as histoplasmosis is sickening a cluster of people in Tennessee.
Dozens of histoplasmosis cases have been reported in middle Tennessee since last�...
